![](/img/cover-not-exists.png)
32. Ibandronate: a well-tolerated new oral bisphosphonate for the treatment of bone metastases.
R.E. Coleman, O.P. Purohit, C. Black, J. Vinholes, J.A. Kanis, K. Schlosser, H. Huss, K.J. QuinnVolume:
4
Year:
1995
Language:
english
DOI:
10.1016/0960-9776(95)90124-8
File:
PDF, 155 KB
english, 1995